| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
8,797,000 | 8,214,000 | 7,549,000 | 7,076,000 | 6,842,000 |
| Cost of Revenue
|
-4,865,000 | -4,422,000 | -3,965,000 | -3,580,000 | -3,535,000 |
|
Gross Profit
|
3,932,000 | 3,792,000 | 3,584,000 | 3,496,000 | 3,307,000 |
| Selling, General and Administrative Expenses
|
-1,327,000 | -1,262,000 | -1,181,000 | -1,193,000 | -1,140,000 |
|
Operating Income/Expenses
|
-1,327,000 | -1,262,000 | -1,181,000 | -1,193,000 | -1,140,000 |
|
Total Operating Profit/Loss
|
2,605,000 | 2,530,000 | 2,403,000 | 2,303,000 | 2,167,000 |
| Total Net Finance Income/Expense
|
-510,000 | -501,000 | -489,000 | -513,000 | -527,000 |
| Net Investment Income
|
2,000 | 6,000 | -27,000 | 2,000 | 20,000 |
| Irregular Income/Expenses
|
1,697,000 | 32,000 | 21,000 | 17,000 | 19,000 |
|
Other Income/Expense, Non-Operating
|
58,000 | 11,000 | -8,000 | 9,000 | -17,000 |
|
Non-Operating Income/Expenses, Total
|
1,247,000 | -452,000 | -503,000 | -485,000 | -505,000 |
|
Pretax Income
|
3,850,000 | 2,077,000 | 1,900,000 | 1,818,000 | 1,662,000 |
|
Provision for Income Tax
|
-407,000 | -518,000 | -414,000 | -221,000 | -337,000 |
|
Net Income from Continuing Operations
|
3,443,000 | 1,559,000 | 1,486,000 | 1,597,000 | 1,325,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
3,443,000 | 1,559,000 | 1,486,000 | 1,597,000 | 1,325,000 |
|
Net Income after Non-Controlling/Minority Interests
|
3,443,000 | 1,559,000 | 1,486,000 | 1,597,000 | 1,325,000 |
|
Net Income Available to Common Stockholders
|
3,443,000 | 1,559,000 | 1,486,000 | 1,597,000 | 1,325,000 |
|
Diluted Net Income Available to Common Stockholders
|
3,443,000 | 1,559,000 | 1,486,000 | 1,597,000 | 1,325,000 |
|
Common Dividend per Share
|
2.96 | 2.84 | 2.68 | 2.42 | 2.28 |
| Basic EPS
|
12.50 | 5.59 | 5.28 | 5.68 | 4.63 |
| Diluted EPS
|
12.42 | 5.55 | 5.22 | 5.59 | 4.57 |
|
Basic Weighted Average Shares Outstanding
|
276,000 | 279,000 | 282,000 | 281,000 | 286,000 |
|
Diluted Weighted Average Shares Outstanding
|
278,000 | 281,000 | 285,000 | 285,000 | 290,000 |
|
Reported Normalized Diluted EPS
|
6.41 | 6.05 | 5.39 | 5.17 | 4.53 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
4,360,000 | 2,578,000 | 2,389,000 | 2,331,000 | 2,189,000 |
|
EBITDA
|
4,604,000 | 2,834,000 | 2,614,000 | 2,531,000 | 2,385,000 |
|
Normalized EBITDA
|
2,935,000 | 2,830,000 | 2,628,000 | 2,581,000 | 2,425,000 |
|
Normalized Income
|
1,780,000 | 1,700,000 | 1,536,000 | 1,475,000 | 1,312,000 |
|
Total Unusual Items
|
-1,669,000 | -4,000 | 14,000 | 50,000 | 40,000 |
12/31/2022 - 9/17/1997
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade